Covaxin’s Phase 3 Trial Data Looks Good, Says Chief Scientist As Bharat Biotech Awaits WHO Approval

0
196

The overall efficacy is quite high. The vaccine efficacy against the Delta variant is low but it is still quite good, said Dr Soumya Swaminathan.